BioCentury | Jul 26, 2019
Preclinical News
July 26 preclinical Quick Takes: Ribon's new mechanism for PARP inhibitors, a microbiome-ALS link and more
...Staff Writers
BMS-986165
BiomX Ltd.
Bristol-Myers Squibb Co.
Cytokinetics Inc.
DayTwo Ltd.
NanoString Technologies Inc.
Ribon Therapeutics Inc.
University of Texas Southwestern Medical Center
Vanderbilt-Ingram Cancer Center
DEAD...